The influenza virus non-structural protein 1 (NS1) is a multifunctional virulence factor that plays a crucial role during infection by blocking the innate antiviral immune response of infected cells. In contrast to the well-studied NS1 protein of influenza A virus, knowledge about structure and functions of the influenza B virus homologue B/NS1, which shares less than 25 % sequence identity, is still limited. Here, we report on a reverse genetic analysis to study the role of a highly conserved class II Src homology 3 domain-binding motif matching the consensus PxxPx(K/R) that we identified at positions 122-127 of the B/NS1 protein. Surprisingly, glycine substitutions in the Src homology 3 domain-binding motif increased virus replication up to three orders of magnitude in human lung cells. Enhanced mutant virus propagation was accompanied by increased gene expression and apoptosis induction linking this motif to the control of programmed cell death. A MS-based interactome study revealed that the glycine substitutions facilitate binding of B/NS1 to heat shock protein 90-beta (HSP90b). Moreover, recruitment of the viral polymerase basic protein 2 to the B/NS1-HSP90b complex was observed. Pharmacological inhibition of HSP90 reduced mutant virus propagation suggesting that the mutation-induced involvement of HSP90b enhanced viral replication. This study not only functionally characterizes a conserved motif within the B/NS1 protein, but also illustrates a rare example in which mutation of a highly conserved sequence within a viral protein does not result in high fitness costs, but rather increases viral replication via recruitment of a host factor.
INTRODUCTION
Influenza A virus (IAV) and influenza B virus (IBV) are prototypic members of the family Orthomyxoviridae and are a major cause of respiratory disease in humans. During seasonal epidemics both virus types co-circulate with varying manifestations, causing about 3-5 million cases of severe illness and about 250 000-500 000 deaths as well as immense economic losses, worldwide (WHO, 2014) . Interactions of IAVs with cellular binding partners have been comprehensively investigated (Karlas et al., 2010; Watanabe et al., 2014; König & Stertz, 2015) . In comparison, this aspect has been considerably less studied with IBV, although this virus type can cause rates of hospitalization and influenza-associated complications similar to seasonal IAV infections and may be the dominating virus type in seasonal epidemics (Glezen et al., 2013) .
IAV and IBV genomes comprise eight ssRNA segments with negative orientation encoding at least 12 (IAV) and 11 (IBV) proteins, respectively (Shaw & Palese, 2013) . Both virus types express a multifunctional non-structural protein 1 (NS1) which counteracts the antiviral type I IFN response (García-Sastre et al., 1998; Talon et al., 2000; Dauber et al., 2004) and inhibits the IFN-inducible protein kinase R in infected host cells (Bergmann et al., 2000; Dauber et al., 2006) . However, the NS1 proteins of IAV and IBV possess less than 25 % sequence identity and have also type-specific functions. For instance, only the NS1 protein of IAV (A/ NS1) interacts with the 30 kDa subunit of cleavage and polyadenylation specificity factor (CPSF 30) and phosphatidylinositol 3-kinase to control maturation of mRNA and to prevent premature apoptosis induction in infected cells (Noah et al., 2003; Ehrhardt et al., 2007a, b; Zhirnov et al., 2002) . In contrast, it is a unique property of the NS1 protein of IBV to bind to the IFN-stimulated gene 15 product and to inhibit its conjugation to cellular targets (Yuan & Krug, 2001) . These divergent NS1 functions may reflect differential adaptations of the two influenza virus types to their specific host spectra. While IAVs are naturally able to infect a range of animal species (e.g. humans, swine, birds, seals and horses), IBV appears to be predominantly limited to humans (Wright et al., 2013; Kim et al., 2015) .
One example for species-specific adaptation is the highly conserved class II Src homology 3 domain-binding motif (SH3-BM) 212-PPLPPK-217 within the NS1 protein of most avian IAV strains, which is uncommon for human A/NS1 proteins (Heikkinen et al., 2008) . SH3-BM mediates the interaction with SH3 domains, which are small protein modules often contained in host factors involved in regulating cellular signalling pathways, cytoskeletal organization and membrane trafficking (Mayer & Saksela, 2004; Li, 2005) . SH3-BM within avian A/NS1 proteins was described to be important for Crk (L) adaptor protein binding (Heikkinen et al., 2008; Ylösm€ aki et al., 2015) . The members of the Crk adaptor protein family are ubiquitously expressed and function as scaffolds for the formation of protein complexes involved in numerous cellular signalling processes (Birge et al., 2009; Liu, 2014) . The Crk adaptor family comprises the two splicing variants CrkI (28 kDa) and CrkII (40 kDa) as well as CrkL, which is encoded by a different gene (Liu, 2014) . Each Crk protein contains one Src homology 2 (SH2) and one (CrkI) or two (CrkII/CrkL) SH3 domains. Hrincius et al. (2010) previously reported that interaction of avian A/NS1 with CrkI/II inhibits IAV-mediated activation of c-Jun N-terminal kinase (JNK) which results in suppressed virus-induced apoptosis. Reduction of cellular CrkI/II protein levels led to slightly decreased avian IAV propagation by half an order of magnitude due to JNK-mediated increase of premature cell death (Hrincius et al., 2010) . Additionally, it was demonstrated that SH3-BM of avian IAV is necessary for c-Abl kinase inhibition resulting in reduced Crk phosphorylation levels as well as cytopathogenic cell alterations upon infection (Hrincius et al., 2014) .
The B/NS1 and A/NS1 proteins consist of about 281 and 230 aa, respectively, with variations among virus strains (Briedis & Lamb, 1982; Hale et al., 2008) . Structural analyses have shown that the N-terminal RNA-binding domains located at positions 1-93 (B/NS1) and 1-73 (A/NS1), respectively, share a similar fold consisting of three a-helical regions that form a homodimeric structure in an entangled sixhelical configuration (Yin et al., 2007) . Recent studies showed that the effector domain covering positions 88-202 of A/NS1 proteins has structural diversity and plasticity, which may allow the effector domain to interact with diverse cellular factors (Hale, 2014) . In contrast, there is no structural information available for the corresponding part of the B/NS1 protein. In terms of function it has been demonstrated that B/NS1 aa 94-281 are capable of inhibiting viral type I IFN induction (Donelan et al., 2004; Dauber et al., 2006) and that positions 94-103 are required to bind ISG15 (Yuan et al., 2002) .
To obtain hints for additional biological activities of the B/ NS1 protein, we aligned and searched the sequences of more than 1200 IBV strains for conserved protein motifs resulting in the discovery of a highly conserved SH3-BM at amino acid positions 122-127. We demonstrate that this SH3-BM mediates binding to CrkII adaptor protein and that disruption of this interaction by substitution of the SH3-BM with glycine residues leads to increased JNK/ATF2 signalling and apoptosis induction in infected cells, linking this motif to the control of programmed cell death. Unexpectedly, the glycine substitutions impressively increased IBV propagation up to three orders of magnitude in human cells. A MS-based approach identified heat shock protein 90-beta (HSP90b) as cellular interaction partner of the B/ NS1 SH3-BM mutant protein. Additionally, viral polymerase basic protein 2 (PB2) was found to interact with the mutation-induced HSP90b-NS1 complex, which might contribute to the SH3-BM mutant phenotype.
RESULTS
Highly conserved SH3-BM does not contribute to the type I IFN antagonization capability of the B/NS1 protein To obtain hints for biological activities mediated by parts of the B/NS1 protein abutting the N-terminal RNA-binding domain, we aligned and searched the NS1 sequences of more than 1200 IBV strains for conserved protein motifs. This led to the identification of a class II SH3-BM at amino acid position 122-127 with the consensus sequence [PxTPx (K/R)], which was conserved in 92.45 % of the analysed sequences (Fig. 1a) . To elucidate the relevance of the SH3-BM for IBV replication, we generated two mutant IBVs using an established reverse genetics system : Mutant P122/5L bears substitutions of the conserved prolines 122 and 125 by leucines to disturb SH3-BM function. For a more severe alteration we replaced five amino acids of the SH3-BM by glycines (P122G/P123G/T124G/ P125G/K127G) in mutant xSH3G (Fig. 1b) . Position 126 is occupied by a natural glycine residue. First, we analysed whether the introduced mutations affected suppression of type I IFN accumulation in supernatants of infected cells (Fig. 1c) . Infection with WT virus led only to minor changes compared to basal IFN secretion levels of mocktreated cells. Recombinant influenza B/Lee/40 NS 1-104 virus lacking the C-terminal NS1 region (aa 105-281) was used in parallel as known strong IFN inducer (Dauber et al., 2006) . Mutations within the conserved SH3-BM had apparently only a minor effect on low IFN levels in the supernatant of infected cells compared to WT virus (Fig. 1c) . Thus, the SH3-BM appears not to be involved in antagonizing viral IFN-b induction.
SH3-BM mediates Crk-B/NS1 binding, inhibition of JNK/ATF2 signalling and apoptosis induction in IBV infected cells
In a next step, we examined whether the SH3-BM in B/NS1 had a role in mediating binding to the CrkII adaptor protein, as such an activity had previously been reported for the class II SH3-BM in NS1 proteins of avian IAV (Heikkinen et al., 2008; Hrincius et al., 2010; Ylösm€ aki et al., 2015) . In fact, coimmunoprecipitation analyses demonstrated complex formation between B/NS1 and endogenous CrkII protein in infected A549 cells (Fig. 2a) . Substitutions within SH3-BM reduced Crk-B/NS1 binding. The double mutation P122/5L resulted in slightly decreased interaction, while complete substitution of SH3-BM reduced Crk binding to background levels (Fig. 2a) . The P122/5L-NS1 mutant protein consistently migrated faster as the WT in SDS gels, but this phenomenon was not further analysed (Figs 2a, 3e and 5b) .
We hypothesized that the SH3-BM-mediated B/NS1-Crk interaction might affect JNK/ATF2 signalling and apoptosis induction during infection (Dhanasekaran & Reddy, 2008; Hrincius et al., 2010) . Therefore, we analysed the activity of the JNK/ATF2 pathway in A549 cells infected with WT, P122/5L or xSH3G virus. Increased ATF2 phosphorylation was detectable 30 min after infection with all three viruses ( Fig. 2b) . Interestingly, infection with the xSH3G virus resulted in sustained ATF2 phosphorylation until 8 h postinfection (p.i.), while ATF2 phosphorylation was hardly detectable in WT and P122/5L infected cells at 2-24 h p.i. (Fig. 2b) . Thus, the entire substitution of SH3-BM within B/NS1 protein caused diminished Crk binding and increased ATF2 activity.
To investigate whether increased ATF2 phosphorylation in xSH3G virus infected cells was accompanied by increased apoptosis induction, we analysed poly(ADP-ribose) polymerase (PARP) cleavage induced by the WT or SH3-BM mutant viruses as a hallmark of effector caspase activation. Clearly, xSH3G virus infected cells showed increased levels of cleaved PARP at 6-24 h p.i. compared to WT and P122/ 5L virus infected cells (Fig. 2b ). To evaluate this finding, we measured caspase-3 and -7 activities in infected A549 cells. Significantly, caspase activity of xSH3G infected cells was increased by about 2.3-fold, while P122/5L infected cells revealed only moderately enhanced caspase activity levels compared to WT virus infected cells (Fig. 2c) . These results link activated JNK/ATF2 signalling with increased apoptosis induction in xSH3G virus infected cells, which indicates that binding of B/NS1 to Crk might suppress pro-apoptotic JNK/ATF2 signalling, although we cannot exclude that another SH3 domain protein might be also involved in apoptosis inhibition.
Glycine substitutions of the SH3-BM (aa 122-127) within B/NS1 protein lead to enhanced viral replication in human cells
The influence of the two SH3-BM mutations on IBV propagation was analysed using human and non-human hosts (Figs 3a, b and S1, available in the online Supplementary Material). Mutations within the NS1 SH3-BM had no or only minor effects for IBV replication in Madin-Darby canine kidney (MDCK) type II cells and in 10-day-old embryonated chicken eggs, in which all viruses replicated efficiently to approximately 5Â10 8 f.f.u. ml À1 (Fig. S1 ). In the human lung epithelial cell lines Calu-3 and A549, the double mutation P122/5L led to slightly increased viral replication compared to WT virus (Fig. 3a, b) . Surprisingly, glycine substitutions of SH3-BM resulted in significantly increased propagation of 2 log units to 1.4Â10 7 f.f.u. ml À1 at 96 h p.i. in Calu-3 cells (Fig. 3a) . This effect was even more pronounced in A549 cells as titres of the xSH3G virus were increased about three orders of magnitude at 72 h p.i. compared to WT virus (Fig. 3b) . The strong propagation of xSH3G virus was accompanied by earlier accumulation of viral NS1, nucleoprotein (NP) and PB2 proteins compared to WT and P122/5L virus in A549 cells (Fig. 3c ). In addition, nucleocytoplasmic relocalization of NP and NS1, a hallmark of late stage infection , was detected earlier in infection, suggesting that the mutated B/NS1 protein enhanced viral replication (Fig. 3d) .
In subsequent analyses, we aimed to elucidate the reason(s) for the stimulating effect of the xSH3G mutation. Previous studies of IAV had suggested that mutations within the A/ NS1 protein can increase viral polymerase activity (Min et al., 2007; Forbes et al., 2012) . In analogy, we hypothesized that mutations within B/NS1 aa 122-127 might enhance IBV polymerase activity and employed a luciferase minigenome assay to compare the activities of the WT and mutant proteins. In fact, co-expression of the xSH3G mutant B/NS segment significantly increased viral gene expression compared to the WT (Fig. 3e) . We also analysed 
Relative luciferase activity (%) a potential role of enhanced apoptosis in infected cells, since induction of caspase activity is known to boost IAV propagation (Ludwig et al., 2006) . Interestingly, IBV WT replication was slightly decreased in the presence of caspase inhibitor Z-DEVD-FMK, suggesting that type B influenza virus also benefits from limited induction of apoptosis (Fig.  S2a) . However, inhibition of caspases did not alter propagation of the xSH3G virus, which in essence eliminates enhanced apoptosis induction as major cause for its phenotype (Fig. S2a) . In addition, we asked if reduced Crk-B/NS1 binding in xSH3G virus infected cells would affect viral propagation. In fact, siRNA-mediated knockdown of Crk slightly decreased IBV WT replication, but hardly altered virus titres of the P122/5L and xSH3G mutants (Fig. S2b) . Thus, we concluded that glycine substitutions within the SH3-BM may increase viral replication by enhancing viral polymerase activity in human cells, but that enhanced apoptosis induction and reduced Crk-B/NS1 binding are unlikely reasons to explain the xSH3G virus phenotype.
Glycine substitutions in the SH3-BM lead to increased B/NS1 binding of cellular chaperone HSP90b
We hypothesized that the biological activities of the WT and mutant B/NS1 proteins are executed by specific interacting host factors. Therefore, we took a MS-based quantitative proteomic approach involving stable isotope labelling by amino acids in cell culture (SILAC) (Meissner & Mann, 2014) and co-immunoprecipitation from lysates of infected cells in order to identify host factor(s) that would be recognized specifically by the B/NS1-xSH3G mutant (Fig. 4) . Cellular proteins bound to the viral B/NS1 proteins were compared in WT virus infected ('light' cells) and xSH3G virus infected A549 cells ('heavy' cells). At 16 h p.i., cell lysates were prepared, mixed and subjected to immunoprecipitation (IP) by B/NS1-specific antibody coupled to protein A agarose. Subsequently, proteins were eluted from the matrix and identified by MS analysis (Fig. 4) . Alterations of B/NS1 protein-protein interactions due to SH3-BM substitutions correspond to changes in the heavy/light (H/L) ratio (Table 1) . Table 1 depicts cellular proteins with increased B/NS1 binding capacity due to xSH3G mutation (H/L>2) including HSP90b, as well as DHX9 , which were previously also described as A/NS1 interacting partners of avian H5N1, swine H3N2 and human H1N1 virus strains, respectively (Lin et al., 2011) .
The cellular chaperone HSP90 stabilizes labile protein conformations which can be induced by only a few amino acid substitutions (Blagosklonny et al., 1996) . It is involved in protein folding, complex formation and regulation of various cellular processes (Fig. 5a ). Interaction of HSP90b with xSH3G-B/NS1 in infected cells was confirmed by co-immunoprecipitation analysis, whereas interaction with WT and P122/5L B/NS1 proteins was hardly detectable (Fig. 5b) . Previous studies have demonstrated that HSP90 interacts with NP as well as with the polymerase subunits of IAV (Naito et al., 2007; Kawaguchi et al., 2012; De Chassey et al., 2013; Watanabe et al., 2014; Jirakanwisal et al., 2015) , and that this interaction stimulates viral polymerase activity (Momose et al., 2002) . Since xSH3G mutation was shown to increase viral polymerase activity (Fig. 3e) , we raised rabbit antiserum to the PB2 of IBV to test the hypothesis that it is also part of the HSP90b-xSH3G-B/NS1 complex. In fact, we were able to demonstrate that PB2 was precipitated by HSP90b in xSH3G, but not in WT virus infected cells (Fig. 5b) . Thus, the glycine substitutions of SH3-BM facilitated strongly increased binding of the cellular chaperone HSP90b to the B/ NS1 protein and recruitment of the viral polymerase subunit PB2. The influence of HSP90 activity on xSH3G virus replication was further investigated using geldanamycin (GA), 
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which inhibits HSP90 activity by binding to its ATPase domain. GA treatment significantly reduced xSH3G propagation in A549 cells demonstrating its supportive role for IBV replication. We concluded that xSH3G mutation introduced into the B/NS1 protein facilitated complex formation of HSP90 with PB2 that may support viral propagation (Figs 3e, 5b and c).
DISCUSSION
The error-prone viral polymerase enables fast adaptation of influenza viruses to changing conditions as well as incorporation of mutations facilitating resistance against antiviral drugs (Shaw & Palese, 2013) . Despite the overall large genetic variability, some influenza virus protein sequences are highly conserved indicating that they function as structural domains with important functions. Here, we identified a highly conserved class II SH3-BM within the B/NS1 protein (aa 122-127) that we characterized by reverse genetics. For the design of B/NS1 mutants, we considered known aspects of SH3-BMs to reduce recognition by a then unknown cellular SH3 domain protein(s): First, the specificity of SH3-BM binding to SH3 domains is influenced by sequences flanking the PxxP motif (Agrawal & Kishan, 2002) . Second, some SH3 domains can bind peptide ligands not conforming to the PxxP consensus (Saksela & Permi, 2012) . Therefore, we generated the B/NS1 mutant P122/5L in which only the conserved two proline residues within the SH3-BM were exchanged for leucines, whereas conversion of the whole motif (aa 122-127) to glycines in the xSH3G mutant was expected to even more pronouncedly affect SH3 domain binding (Fig. 1b) . The capability of B/NS1 to antagonize the IFN response and to accumulate in nuclear speckles of infected cells was not altered by any of the SH3-BM substitutions, suggesting that they did not cause a major disturbance in overall protein structure (Figs 1c, 3d) .
Co-immunoprecipitation analysis identified the SH3-BM of B/NS1 as a likely ligand of the cellular CrkII protein as both SH3-BM mutants were affected in their ability to bind Crk. While P122/5L-Crk binding was moderately decreased, xSH3G binding to Crk was reduced to background levels (Fig. 2a) . Functional investigations of the Crk-B/NS1 interaction revealed that infection with xSH3G mutant virus activated the antiviral-acting JNK/ATF2 pathway and triggered apoptosis induction (Fig. 2b, c) . These results indicate that the flanking amino acids of PxxP motif contribute to SH3 domain binding and that even a weakened Crk-B/NS1 interaction is sufficient to inhibit downstream signalling during IBV infection. Crk knockdown reduced WT virus propagation about half an order of magnitude, but had no effect for SH3-BM mutant virus replication (Fig. S2b) . This finding supports the hypothesis that the highly conserved SH3-BM within B/NS1 has evolved to prevent apoptosis in the early phase of IBV replication by suppression of JNK signalling, similar to the mechanism previously reported for A/NS1 proteins of avian origin (Hrincius et al., 2010) . IBV may thereby compensate the lack of the B/NS1 protein to trigger survival signals through activation of the PI3K/Akt pathway, which is a conserved function among the NS1 proteins of IAV (Ehrhardt et al., 2007a) .
Unexpectedly, in comparison to WT virus, a robust increase of viral replication as well as accelerated gene expression and nucleocytoplasmic relocalization of viral proteins were detected for the xSH3G mutant virus in human cells (Fig. 3) , suggesting gain of a novel activity that we hypothesized to rely on recruitment of a host protein. A selective MS-based SILAC approach identified seven cellular proteins that bound preferentially to the mutated B/NS1 protein (Table 1) and could thereby contribute to the increased xSH3G virus replication (Fig. 4) . STRING network analysis revealed their participation in cellular functions like RNA processing (DDX42, DHX9, HNRNPU), response to unfolded proteins/stress and regulation of apoptotic process Table 1 . Identification of xSH3G-B/NS1 interaction partners using SILAC-MS/MS analysis H/L ratios of cellular proteins are organized from the potential strongest xSH3G-B/NS1 interactor (H/L>1) to proteins that bind more efficiently to WT-B/NS1 protein (H/L<1). The Uniprot ID, protein name, molecular mass and peptide scores for the cellular proteins are shown. The peptide score is the sum of the scores of the individual peptides that identified the protein. The number of PSMs designates the total number of identified peptide spectra matched for the protein. 'Coverage' indicates the percentage of the protein sequence covered by the identified peptides. The H/L count indicates the number of peptide ratios that were actually used to calculate a particular protein ratio, whereas H/L variability indicates the variability of these peptide ratios from the particular H/L protein ratio. (HSPA5, HSP90AB1, PHB) (Fig. 5a) . One of the identified xSH3G-B/NS1 interaction partners is the cellular chaperone HSP90b (HSP90AB1). Co-immunoprecipitation analysis confirmed not only binding of the B/NS1 xSH3G protein to HSP90b, but also an increased interaction of HSP90b with the viral PB2 polymerase subunit in human cells (Fig. 5b) . Inhibition of HSP90 by GA significantly decreased virus propagation, suggesting that the chaperone contributes to the mutant phenotype (Fig. 5c ).
Mechanistic interpretation of the data must be done with caution as functions of HSP90 and regulation of viral polymerase by the NS1 protein have been explored only for IAV, whereas these aspects are virtually unknown for IBV. Thus, HSP90 stimulates viral ribonucleoprotein (vRNP) complex formation of IAV, viral RNA synthesis and replication as well as apoptosis induction (Momose et al., 2002; Naito et al., 2007; Chase et al., 2008; Zhang et al., 2011) . Moreover, the A/NS1 protein interacts with vRNP complexes, which may be the basis for its regulatory activity on viral RNA synthesis (Shimizu et al., 1994; Marión et al., 1997; Min et al., 2007; Robb et al., 2011) . Thus, our findings support a hypothetical model explaining the increased xSH3G replication by the formation of a complex comprising HSP90b, PB2 and xSH3G-B/NS1 that supports enhanced formation of the viral polymerase complex and facilitates increased viral gene expression and propagation. Clearly, the detailed role(s) of the B/NS1-HSP90b interaction and its role for enhanced IBV replication efficiency specifically in human cells require further investigations.
In general, highly conserved sequences are considered to be structural domains with essential protein functions (Sitbon & Pietrokovski, 2007; Ashkenazy et al., 2010) . However, substitution of the conserved SH3-BM strongly increased IBV propagation which contradicted the expectation that mutation of this conserved site would result in high fitness costs. To the best of our knowledge there are only a few precedents for such a phenotype reported in the literature, none of which involved influenza viruses (Sen et al., 2008; Rolland et al., 2013; Watkins et al., 2013) . This study therefore not only characterizes a novel motif within the B/NS1 protein but also documents that mutations within a viral factor can result in the gain of unexpected protein-protein interactions and activities, such as recruitment of HSP90b. The xSH3G mutation alters local basic properties of SH3-BM due to glycine substitution of the lysine residue at position 127 and strengthens the hydrophobic property of the motif (Trinquier & Sanejouand, 1998; Biswas et al., 2003) . Based on the current state of knowledge, it is still impossible to predict that the particular mutation would increase binding to HSP90b (Karagöz & Rüdiger, 2015) or other proteins listed in Table 1 , and confers a growth advantage in human cells. Therefore, findings from this study may also serve as a reminder of the possibility of unintended similar biological effects when analysing viral proteins by the use of -usually hypothesis driven -reverse genetics.
METHODS
Protein sequence alignments. BLAST alignments of all available (1206) B/NS1 sequences submitted to National Center for Biotechnology Information (NCBI) database using BIOEDIT 7.2.5 software identified the SH3-BM as a highly conserved motif within the influenza B/NS1 protein (as accessed on July 7, 2016) (Altschul et al., 1990; Hall, 1999) .
Cells and viruses. MDCK type II cells and Calu-3 cells were grown in minimal essential medium (MEM) supplemented with 10 % (v/v) FCS, 2 mM L-glutamine and antibiotics. HEK 293T and A549 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with the same additives. All cells were maintained at 37 C and 5 % CO 2 . Stocks of the recombinant IBV strain B/Lee/40, which is attenuated in humans (Beare et al., 1977) as well as the IBV mutants P122/5L and xSH3G were grown in the allantoic cavities of 10-day-old embryonated chicken eggs for 3 days at 33 C. The IBV mutant 'NS 1-104' was amplified in 7-day-old chicken eggs (Dauber et al., 2006) . To analyse viral replication, confluent A549, Calu-3 and MDCK cell cultures were infected at the indicated m.o.i. and incubated for 72 or 96 h at 33 C in culture medium containing 0.2 % (w/v) BSA and trypsin. Viral propagation in 10-day-old embryonated chicken eggs was analysed by infecting chicken eggs with 500 f.f.u. in 100 µl PBS and incubation for 3 days at 33 C. To achieve inhibition of cellular apoptosis, infected A549 cells were treated with 70 µM caspase-3 inhibitor Z-DEVD-FMK (BD Biosciences). Virus titres were determined on MDCK cells by counting the numbers of fluorescent plaques after infection and indirect immunofluorescence staining with NP-specific antibody. Titres were correspondingly expressed as fluorescent-forming units per millilitre.
Plasmids and antibodies. The constructs pHW-Lee-NS-P122L/ P125L (P122/5L) and pHW-Lee-NS-P122G/P123G/T124G/P125G/ K127G (xSH3G) are derivatives of pHW-Lee-NS-XhoI , and were generated with inverse PCR using the primers 5¢-cgatacctgc caaccctggg aaagtacctt gatgacatag aagaagagc-3¢ (forward) and 5¢-cgatccaggg ttggcaggta atcggtccaa tcgtaatttg gacatttgc-3¢ (reverse) or 5¢-cgatgcggta ccttgatgac atagaagaag agccggaaaa tgtcg-3¢ (forward) and 5¢-cgatggtacc ctcctccgcc tccaccgtaa tcggtccaat cgtaatttgg-3¢ (reverse), respectively. The inserted mutations at aa 122-127 did not affect the nuclear export protein (NEP). The integrities of the constructs were confirmed by DNA cycle sequencing using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems/Life Technologies).
Polyclonal anti-B/PB2 antiserum was generated in rabbits immunized with recombinant GST-PB2 (aa 535-759) protein of the B/Lee/40 virus strain and was affinity-purified by means of recombinant B/PB2 protein expressed in Escherichia coli. In addition, B/NS1-specific rabbit antiserum (Dauber et al., 2006) , mouse anti-B/NP (AbD Serotec), mouse anti-Crk (BD Biosciences), mouse anti-HSP90b (Acris), rabbit anti-phospho-ATF2 (Cell Signaling), rabbit anti-ATF2 (Cell Signaling), rabbit anti-PARP (Cell Signaling), mouse anti-actin (SigmaAldrich), mouse anti-tubulin (Sigma-Aldrich) and mouse anti-V5 tag (AbD Serotec) as well as suitable secondary HRP-conjugated goat anti-rabbit or rabbit anti-mouse antibodies were used to precipitate and detect proteins, respectively. For immunofluorescence analyses, species-specific secondary IgG conjugated with Alexa Fluor dyes (anti-rabbit-488, anti-mouse-594; Life Technologies) were used as secondary antibodies.
Transfection-mediated recovery of recombinant IBV and reverse transcription PCR analysis. To generate recombinant P122/5L and xSH3G IBVs, we employed an established eight plasmid reverse genetics system . The presence of the introduced mutations and the absence of unexpected nucleotide alterations in the respective NS genes were confirmed by cycle sequencing of amplified reverse transcription PCR products.
Immunoprecipitation and immunoblot analysis. A549 cells were mock-treated or infected with WT, P122/5L or xSH3G mutant virus at an m.o.i. of 10. Cell extracts were prepared for 8 h p.i. in IP lysis buffer [0.5 % (v/v) IGEPAL (Fluka Biochemika), 100 mM NaCl, 50 mM Tris/HCl pH 7.5, 1 mM EDTA, 1 % (v/v) Triton X-100, 10 mM sodium-b-glycerophosphate, 2 mM Na 3 VO 4 , 1 mM Pefabloc]. After centrifugation, 500 µl aliquots of lysates were precleared by rotation with 20 µl unloaded protein-G-agarose beads (Roche) for at least 30 min at 4 C. Afterwards, the precleared lysates were again centrifuged andincubated with indicated antibodies for 16 h at 4 C. Immune complexes were collected on protein-G-agarose beads (Roche), washed and the precipitated proteins were dissolved in SDS sample buffer. The precipitated proteins were analysed by SDS gel electrophoresis and immunoblotting using antibodies as indicated. To analyse phosphorylation of ATF2 or PARP cleavage, A549 cells were mock-treated or infected with WT, P122/5L or xSH3G viruses at an m.o.i. of 10. Cell extracts were prepared at indicated time points in IP lysis buffer and subjected to SDS-PAGE and immunoblot analysis. Proteins were detected with specific primary and suitable secondary antibodies together with an enhanced chemiluminescence protocol (Thermo Fisher Scientific).
Confocal laser scanning microscopy. IAV infected HeLa cells (m.o.i. 2) were used for indirect immunofluorescence staining as described previously (von Recum-Knepper et al., 2015) . Influenza virus proteins were detected with the indicated primary and species-specific secondary antibodies. Imaging of cells was performed using an LSM 510 Meta confocal laser scanning microscope and a C-Apochromat 63x/1.2 water objective lens (Zeiss) with a pinhole setting of 1. Data were analysed and processed with the Zeiss LSM Image Browser 3.5 and Adobe Photoshop CS5 software packages.
RNA polymerase activity assay. To compare the effect of mutant B/ NS gene segments on viral polymerase activity, a luciferase reporter minigenome assay was used (Wunderlich et al., 2010) . Briefly, 293T cells were transiently transfected with sets of plasmids expressing PB1, polymerase acidic protein (PA), PB2 (50 ng of each) and NP (100 ng) and pPol-B/NS-Luc (125 ng) encoding a firefly luciferase cDNA of negative polarity flanked by the non-coding regions of the viral B/NS segment. The constitutive expression vector pTK-RL (Promega) was used to normalize for transfection efficiency (5 ng). The effect of WT and mutant B/NS segments was analysed by co-transfection of the respective pHWLee-B/NS construct (250 ng). siRNA-mediated gene knockdown. AllStars Neg. Control siRNA (ID: 1027281) and siRNA targeting Crk (sense agaucaagaguuugauucaaatt, antisense uuugaaucaaacucuugaucucc) were purchased from Qiagen. A549 cells seeded in 12-well plates were transfected with 25 pmol siRNA and 4 µl Lipofectamine 2000 (Qiagen). Twenty-four hours after transfection, cells were infected with virus at an m.o.i. of 0.1. Supernatants were collected 48 h p.i. and virus titres were measured as described above. Knockdown efficiencies were determined by immunoblot analysis.
Caspase activity. To determine caspase-3 and -7 activities, A549 cells were infected with the indicated viruses at an m.o.i. of 10 or mocktreated. Caspase activity was analysed with Caspase-Glo 3/7 assay (Promega) at 19 h p.i. and 10 µM staurosporine was used as positive control.
Identification and quantification of NS1 interaction partners by SILAC-based MS. A549 cells were grown in SILAC-DMEM (PAA Laboratories) containing either light (R0K0: R= 12 C 6, K= 12 C 6 ) or heavy (R6K6: R= 13 C 6 , K= 13 C 6 ) arginine and lysine for at least six cell doublings prior to infection. A total number of 8Â10 7 heavy-labelled cells were infected with xSH3G mutant virus at an m.o.i. of 4, while the same number of light-labelled cells served as a WT virus infected control. At 16 h p.i., cell extract of each population (heavy and light) was prepared in 1 ml of lysis buffer [50 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 % (v/v) IGEPAL, 1 mM EDTA, 10 mM sodium-b-glycerophosphate, 2 mM Na 3 VO 4 , 1 mM Pefabloc]. The protein concentration of each lysate was determined by BCA protein assay (Thermo Fisher Scientific), and the lysates were mixed at a 1 : 1 H/L ratio, followed by selection of NS1 bound proteins by B/NS1-specific rabbit antiserum coupled to protein-A-agarose resin (Roche) at 4 C for 16 h. Precipitated proteins were eluted in 2Â SDS sample buffer for 5 min at 95 C and separated by SDS-PAGE. A gel lane was cut into 20 slices, which were then reduced and alkylated by addition of 10 mM DTT (1 h, 60 C) and 5 mM iodoacetamide (1 h, 22 C, in the dark). Proteins were then subjected to in-gel tryptic digestion using a trypsin profile IGD kit (Sigma). The resulting peptides were separated and measured using an Easy Nano liquid chromatography II system coupled to an LTQ Orbitrap discovery XL (Thermo Fisher Scientific) (Berri et al., 2014) .
Raw data files were evaluated using Proteome Discoverer software (version 1.4; Thermo Fisher Scientific). Proteins were identified by searching against the NCBI -Homo sapiens database (33 286 sequences) using the SEQUEST algorithm and the following search parameters: carbamidomethylation of cysteine (57.021) as a fixed modification; oxidation of histidine, methionine and tryptophan (15.995) and appropriate SILAC labels as variable modifications; tryptic digestion with a maximum of two missed cleavages; a peptide precursor mass tolerance of 10 p.p.m. and a fragment mass tolerance of 0.8 Da. The decoy database search option was enabled and all peptides were filtered with a maximum false discovery rate of 5 %. Protein quantification was performed with unique peptides and a mass precision of 2 p.p.m. The relative abundance of a protein in the NS1 protein complex was derived from its H/L ratio in the differently labelled cell populations. Quantification values outside the range from 0.01 to 100 were recorded as 0.01 (ratio 0.01) and 100 (ratio !100). An H/L ratio of 2 for a given protein was considered to signal increased abundance in the xSH3G-NS1 protein complex. STRING network analysis (version 10) was used as search tool for the retrieval of interacting proteins and their clustering according to protein functions.
